MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital
Commits to Capital Return of Up to $3.15 per Share Adds Three New Directors and Forms Capital Allocation Committee of the Board ...
Source: marketscreener.com
Page 7 - Initial Statements News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Initial Statements. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Initial Statements Today - Breaking & Trending Today
MEI Pharma Recommends Stockholders Not to Consent
Files Definitive Consent Revocation Statement Mails Letter to Stockholders Highlighting the Path to Realizing the Full Value of Their MEI Investment Urges Stockholders Not to be Misled by Anson...
Source: marketscreener.com
Bristol Myers Squibb : BMY-MRTX Factsheet -October 08, 2023 at 08:48 pm EDT
Bristol Myers Squibb to Acquire Mirati Therapeutics Transaction Terms and Financial Details ...
Source: marketscreener.com
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Thera
Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value Right Acquisition Brings KRAZATI® (adagrasib), a Best-in-Class KRASG12C Inhibitor Approved by the U.S. FDA for the Treatment of Patients with Advanced Non-Small Ce...
Source: pharmiweb.com
Bristol Myers Squibb : BMY-MRTX Investor Presentation -October 08, 2023 at 08:48 pm EDT
Bristol Myers Squibb Strengthens & Diversifies Oncology Portfolio with Acquisition of Mirati Therapeutics October 8, 2023 Not for Product...
Source: marketscreener.com